SCYNEXIS, Inc. Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party
SCYNEXIS, Inc. (SCYX) reported Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty · last filed 2016-03-07
- SCYNEXIS, Inc. related party transaction, selling, general and administrative expenses from transactions with related party for the quarter ending 2015-12-31 was $0.00.
- SCYNEXIS, Inc. related party transaction, selling, general and administrative expenses from transactions with related party for the quarter ending 2015-09-30 was $0.00.
- SCYNEXIS, Inc. related party transaction, selling, general and administrative expenses from transactions with related party for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. related party transaction, selling, general and administrative expenses from transactions with related party for the quarter ending 2015-03-31 was $0.00.
- SCYNEXIS, Inc. related party transaction, selling, general and administrative expenses from transactions with related party for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- SCYNEXIS, Inc. related party transaction, selling, general and administrative expenses from transactions with related party for fiscal 2014 was $500.00K.
| Period end | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party 3 month | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party 6 month | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party 9 month | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $0.00 derived: sum of 2 quarters · filed 2016-03-07 | $0.00 derived: sum of 3 quarters · filed 2016-03-07 | $0.00 10-K · filed 2016-03-07 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | $0.00 derived: sum of 4 quarters · filed 2016-03-07 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-19 | $0.00 10-Q · filed 2015-08-19 | $0.00 derived: sum of 3 quarters · filed 2016-03-07 | $0.00 derived: sum of 4 quarters · filed 2016-03-07 |
| 2015-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2016-03-07 | $0.00 derived: sum of 2 quarters · filed 2016-03-07 | $0.00 derived: sum of 3 quarters · filed 2016-03-07 | $500.00K derived: sum of 4 quarters · filed 2016-03-07 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $0.00 derived: sum of 2 quarters · filed 2016-03-07 | $500.00K derived: sum of 3 quarters · filed 2016-03-07 | $500.00K 10-K · filed 2016-03-07 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 | $500.00K derived: sum of 2 quarters · filed 2015-11-13 | $500.00K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $500.00K 10-Q · filed 2015-08-19 | $500.00K 10-Q · filed 2015-08-19 | ||
| 2013-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $0.00 8-K · filed 2015-10-30 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |